Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
3.130
-0.080 (-2.49%)
At close: Oct 17, 2025, 4:00 PM EDT
3.120
-0.010 (-0.32%)
After-hours: Oct 17, 2025, 4:10 PM EDT
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $43.15 million as of October 17, 2025. Its market cap has increased by 39.51% in one year.
Market Cap
43.15M
Enterprise Value
23.14M
1-Year Change
39.51%
Ranking
Category
Stock Price
$3.13
Market Cap Chart
Since October 24, 2011, Grace Therapeutics's market cap has decreased from $87.20M to $43.15M, a decrease of -50.52%. That is a compound annual growth rate of -4.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 43.15M | 13.77% |
| Dec 31, 2024 | 37.92M | 39.61% |
| Dec 29, 2023 | 27.16M | 21.53% |
| Dec 30, 2022 | 22.35M | -59.95% |
| Dec 31, 2021 | 55.80M | 77.21% |
| Dec 31, 2020 | 31.49M | -84.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |